{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:14:36Z","timestamp":1790507676404,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/mt.2014.204","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T12:17:48Z","timestamp":1414585068000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Jordi","family":"Martinez-Quintanilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.204_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.204_bib2","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1158\/0008-5472.CAN-06-4675","article-title":"ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2014.204_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nurt.2009.04.011","article-title":"Oncolytic viral therapy of malignant glioma","volume":"6","author":"Parker","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1038\/mt.2014.204_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.mt.6300396","article-title":"A phase I trial of Ad.hIFN-beta gene therapy for glioma","volume":"16","author":"Chiocca","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib6","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1200\/JCO.2003.21.13.2508","article-title":"Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results","volume":"21","author":"Lang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2014.204_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.yexcr.2010.11.017","article-title":"Hyaluronan in human malignancies","volume":"317","author":"Sironen","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1038\/mt.2014.204_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/cam.2.3.6320","article-title":"Role of hyaluronan in glioma invasion","volume":"2","author":"Park","year":"2008","journal-title":"Cell Adh Migr"},{"key":"10.1038\/mt.2014.204_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/mt.2010.79","article-title":"Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth","volume":"18","author":"Guedan","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.10668","article-title":"Hyaluronidase reduces human breast cancer xenografts in SCID mice","volume":"102","author":"Shuster","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1038\/mt.2014.204_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/nor195","article-title":"Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells","volume":"14","author":"Wakimoto","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1038\/mt.2014.204_bib12","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1158\/0008-5472.CAN-08-3886","article-title":"Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors","volume":"69","author":"Wakimoto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2014.204_bib13","first-page":"21","article-title":"Oncolytic viral therapy: targeting cancer stem cells","volume":"2014","author":"Smith","year":"2014","journal-title":"Oncolytic Virother"},{"key":"10.1038\/mt.2014.204_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/mt.2008.228","article-title":"Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM","volume":"17","author":"Markert","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PPO.0b013e3182458b13","article-title":"Gene and viral therapy for glioblastoma: a review of clinical trials and future directions","volume":"18","author":"Mohyeldin","year":"2012","journal-title":"Cancer J"},{"key":"10.1038\/mt.2014.204_bib16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2174\/138920112800958814","article-title":"Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress","volume":"13","author":"Kaur","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1038\/mt.2014.204_bib17","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mt.2011.100","article-title":"Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma","volume":"19","author":"Ahmed","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.expneurol.2003.10.016","article-title":"CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels","volume":"190","author":"Ma","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2014.204_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2741\/2721","article-title":"Biomimetic material systems for neural progenitor cell-based therapy","volume":"13","author":"Potter","year":"2008","journal-title":"Front Biosci"},{"key":"10.1038\/mt.2014.204_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/neuonc\/noq002","article-title":"A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem\/progenitor cells","volume":"12","author":"Hansen","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1038\/mt.2014.204_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2011.04.007","article-title":"Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine","volume":"155","author":"Prestwich","year":"2011","journal-title":"J Control Release"},{"key":"10.1038\/mt.2014.204_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nn.3019","article-title":"Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas","volume":"15","author":"Kauer","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2014.204_bib23","doi-asserted-by":"crossref","first-page":"dju090","DOI":"10.1093\/jnci\/dju090","article-title":"Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy","volume":"106","author":"Duebgen","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2014.204_bib24","article-title":"Engineering toxin-resistant therapeutic stem cells to treat brain tumors","author":"Stuckey","year":"2014","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2014.204_bib25","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.081626898","article-title":"Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors","volume":"98","author":"Pluen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.204_bib26","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.biomaterials.2013.06.024","article-title":"Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid","volume":"34","author":"Pedron","year":"2013","journal-title":"Biomaterials"},{"key":"10.1038\/mt.2014.204_bib27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0883073808321771","article-title":"Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas","volume":"23","author":"Maria","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1038\/mt.2014.204_bib28","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1089\/104303400750035744","article-title":"Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy","volume":"11","author":"Kuriyama","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.204_bib29","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1158\/0008-5472.CAN-05-2242","article-title":"Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector","volume":"66","author":"McKee","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2014.204_bib30","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-07-4732","article-title":"Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models","volume":"14","author":"Ganesh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2014.204_bib31","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1158\/0008-5472.CAN-07-3107","article-title":"Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus","volume":"67","author":"Mok","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2014.204_bib32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/gt.2012.42","article-title":"Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation","volume":"20","author":"Thaci","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.204_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3340\/jkns.2009.46.5.472","article-title":"The effect of hyaluronic Acid on the invasiveness of malignant glioma cells: comparison of invasion potential at hyaluronic Acid hydrogel and matrigel","volume":"46","author":"Jin","year":"2009","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1038\/mt.2014.204_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-3163-5-2","article-title":"Expression of hyaluronan in human tumor progression","volume":"5","author":"Boregowda","year":"2006","journal-title":"J Carcinog"},{"key":"10.1038\/mt.2014.204_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2014.204_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/0008-5472.686.65.3","article-title":"Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase\/Akt pathway to enhance the motility of human glioma cells","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2014.204_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.20306","article-title":"Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression","volume":"57","author":"Shah","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2014.204_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/156652309789753347","article-title":"Stem cells as delivery vehicles for oncolytic adenoviral virotherapy","volume":"9","author":"Kranzler","year":"2009","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2014.204_bib39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jnci\/djt141","article-title":"A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy","volume":"105","author":"Ahmed","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2014.204_bib40","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-08-3076","article-title":"Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2014.204_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12015-011-9312-0","article-title":"Immunosuppressive properties of mesenchymal stem cells","volume":"8","author":"Abumaree","year":"2012","journal-title":"Stem Cell Rev"},{"key":"10.1038\/mt.2014.204_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jnci\/djr509","article-title":"Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells","volume":"104","author":"Kanai","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2014.204_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(98)00204-3","article-title":"The impact of extracellular matrix on chemoresistance of solid tumors\u2013experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy","volume":"131","author":"Baumgartner","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1038\/mt.2014.204_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","article-title":"Mesenchymal stem cells engineered for cancer therapy","volume":"64","author":"Shah","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/mt.2014.204_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/157488812799859865","article-title":"Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question","volume":"7","author":"Somoza","year":"2012","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1038\/mt.2014.204_bib46","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2010.173","article-title":"Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses","volume":"18","author":"Rojas","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.204_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/hum.2006.17.929","article-title":"Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses","volume":"17","author":"Cascallo","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.204_bib48","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/stem.1355","article-title":"Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors","volume":"31","author":"Martinez-Quintanilla","year":"2013","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2014.204_bib49","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.0806647106","article-title":"Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy","volume":"106","author":"Sasportas","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.204_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-012-1008-z","article-title":"Real-time multi-modality imaging of glioblastoma tumor resection and recurrence","volume":"111","author":"Hingtgen","year":"2013","journal-title":"J Neurooncol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T15:48:59Z","timestamp":1668786539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616300168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1525001616300168"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.204","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2014.204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}